Latest News for: nanobody

Edit

MLTX 2-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority ...

Nasdaq Globe Newswire 13 Dec 2025
Investors who lost money in MLTX after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman ... .
Edit

MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit - Hagens Berman Scrutinizing Nanobody Superiority Claims After 90% Plunge; December Lead Plaintiff Deadline Looms

PR Newswire 12 Dec 2025
The Nanobody Deception ... "We are focusing on the repeated assurances MoonLake gave investors about the supposed 'superiority' of their Nanobody technology.
Edit

MLTX 4-DAY DEADLINE ALERT: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority ...

Nasdaq Globe Newswire 11 Dec 2025
Investors who lost money in MoonLake after its stock plunged 90% due to allegedly misleading financial statements are urged to contact Hagens Berman ... .
Edit

MLTX Investor Deadline Alert: MoonLake (MLTX) Class Action Lawsuit – Hagens Berman Scrutinizing Nanobody Superiority ...

Business Wire 10 Dec 2025
MLTX) is rapidly approaching. December 15, 2025.
Edit

MoonLake's (MLTX) SLK Efficacy Claims Under Scrutiny After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority- Hagens Berman

PR Newswire 03 Dec 2025
We are scrutinizing whether the failure of the Nanobody structure to provide superior efficacy was misrepresented to investors ... The Nanobody-Efficacy Disclosure Gap ... Nanobody Superiority.
Edit

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake’s SLK Efficacy Claims After 90% Plunge; Focus on Nanobody ...

Nasdaq Globe Newswire 02 Dec 2025
Did SLK’s Nanobody Structure Truly Confer a Superior Clinical ...
Edit

MLTX Lawsuit: Hagens Berman Scrutinizing MoonLake's SLK Efficacy Claims After 90% Plunge; Focus on Nanobody vs. BIMZELX Superiority

PR Newswire 02 Dec 2025
Did SLK's Nanobody Structure Truly Confer a Superior Clinical Benefit Over Monoclonal Antibodies? ... We are scrutinizing whether the failure of the Nanobody structure to provide superior efficacy was misrepresented to investors ... Nanobody Superiority.
Edit

Chinese scientists develop broad-spectrum nanobodies for tick fever treatment

People Daily 21 Nov 2025
20 (Xinhua) -- A Chinese research team has developed a combination of nanobodies that shows potent and broad efficacy against Severe Fever with Thrombocytopenia Syndrome (SFTS), a severe infectious disease commonly known as tick fever.
Edit

MoonLake’s Nanobody Miss Triggers Investor Lawsuit (Levi & Korsinsky LLP)

Public Technologies 19 Nov 2025
). MoonLake promised a next generation breakthrough. Smaller nanobody. Better tissue reach ... On March 10, 2024, executives told investors their nanobody could do what old antibodies could not ... On March 8, 2025, they called nanobodies a leap forward ... (noodl.
Edit

Nanobodies from alpacas and llamas could hold the key to a universal antivenom

Chemistry World 07 Nov 2025
Novel nanobody mix protects against 17 African snake species ....
Edit

Nanobodies from camels and llamas offer promise for treating schizophrenia and Alzheimer's disease

Phys Dot Org 05 Nov 2025
Nanobodies—tiny proteins derived from ...
Edit

Extracellular nanobody screening using conformationally stable GPCR variants

PNAS 04 Nov 2025
.
Edit

Nanobody-based antivenom shows effectiveness against 17 African snake species

Phys Dot Org 29 Oct 2025
....
Edit

ME Therapeutics Granted Licence for CD22 Nanobody Asset to Expand Next-Gen In Vivo CAR Cell ...

Hastings Tribune 16 Oct 2025
VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct 16, 2025-- ... .
Edit

Nanobody-guided approach enables efficient fluorescent labeling of endogenous proteins

Phys Dot Org 13 Oct 2025
The new approach, termed ALFA Nanobody-guided Endogenous Labeling (ANGEL), solves a ...

Article Search

tools
×
×
×
×